CLINICAL_TRIALS
trial_result
· 2021-07-26
Clinical Trial Update: (-)- Epicatechin Becker Muscular Dystrophy [Phase 2]
Summary
Phase 2 clinical trial update for (-)- epicatechin in Becker Muscular Dystrophy has completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Craig McDonald, MD | Conditions: Becker Muscular Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2021-07-26